Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s stock price traded up 1% during trading on Wednesday. The company traded as high as €33.14 and last traded at €32.84. Approximately 151,057 shares were traded during mid-day trading, an increase of 60% from the average daily volume of 94,405 shares. The stock had previously closed at €32.50.
Carl Zeiss Meditec Stock Down 0.8%
The business’s 50 day simple moving average is €31.24 and its two-hundred day simple moving average is €28.46. The stock has a market capitalization of $3.05 billion, a P/E ratio of 17.50, a price-to-earnings-growth ratio of 2.83 and a beta of 1.35.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
